Connect with us

Hi, what are you looking for?

World

Monsanto ordered to pay $80 mn in Roundup cancer trial

-

Monsanto was ordered on Wednesday to pay some $80 million to an American retiree who blames his cancer on the agribusiness giant's weedkiller Roundup, in a case that could influence the outcome of thousands more like it.

A San Francisco jury found the firm, which is owned by Bayer, had been "negligent by not using reasonable care" to warn of the risks of its product, ordering it to pay Edwin Hardeman $75 million in punitive damages, a little over $5 million in compensation and $200,000 for medical expenses.

The jury also found that Roundup's design was defective and that the product lacked sufficient warnings of potential risk.

The same jury had previously found that a quarter century exposure to Roundup, whose principal ingredient is controversial chemical glyphosate, was a "substantial factor" in giving the 70-year-old Hardeman non-Hodgkin's lymphoma.

The verdict marks a major setback for Bayer, which purchased Monsanto last year for $63 billion and has seen its shares plunge because of the litigation.

A San Francisco jury found that Roundup's design was defective and that the product lacked suff...
A San Francisco jury found that Roundup's design was defective and that the product lacked sufficient warnings of potential risk
JOSH EDELSON, AFP/File

The company, which is facing thousands more similar lawsuits in the United States, said it would appeal the verdict even though it sympathized with Hardeman's plight.

"We are disappointed with the jury's decision, but this verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic," Bayer said in a statement.

"The verdict in this trial has no impact on future cases and trials, as each one has its own factual and legal circumstances."

Hardeman's attorneys, who cheered and hugged their client as the verdict was announced, described the decision by the six-member jury as historic and said it sends a clear message to Monsanto that it needs to change its business practices.

"It is clear from Monsanto's actions that it does not care whether Roundup causes cancer, focusing instead on manipulating public opinion and undermining anyone who raises genuine and legitimate concerns about Roundup," attorneys Aimee Wagstaff and Jennifer Moore said in a statement.

"It speaks volumes that not one Monsanto employee, past or present, came live to trial to defend Roundup's safety or Monsanto's actions."

- 'Back against the wall' -

The case is one of more than 11,200 similar cases in the US alone involving Roundup.

Last year, Monsanto lost a case to a California school groundskeeper suffering from terminal non-Hodgkin's lymphoma, who had sued the company over the glyphosate weedkillers Roundup and Ranger Pro.

Monsanto was initially ordered to pay $289 million to Dewayne Johnson, before the damages were reduced to $78.5 million

Bayer has also filed an appeal in that case.

Monsanto has consistently denied that the weedkiller causes cancer and challenged findings by the International Agency for Research on Cancer, an arm of the World Health Organization (WHO), which classified glyphosate as a "probable carcinogen" in 2015.

But other major agencies like the European Food Safety Authority (EFSA), the European Chemicals Agency (ECHA) or the US Environmental Protection Agency (EPA) have not followed suit.

The weedkiller glyphosate
The weedkiller glyphosate
Alain BOMMENEL, Laurence SAUBADU, Kun TIAN, AFP

Carl Tobias, a law professor at the University of Richmond, told AFP that Hardeman's case was "important as a bellwether, which means it helps predict how future cases will be decided."

Tobias said the verdict "bodes well" for plaintiffs in the thousands of other cases filed against Monsanto, and was "likely to encourage plaintiffs and their counsel to be more vigorous in pursuing their cases and will lead more potential plaintiffs to file suit."

The Environmental Working Group, a non-profit, cheered Wednesday's verdict.

"Clearly, the testimony that informed the jury's decision was Bayer-Monsanto hiding Roundup's carcinogenic properties, manipulating the science and cozying-up with EPA so it would not have to warn consumers of its dangerous product," said the group's president Ken Cook.

"This verdict puts Bayer's back firmly up against the wall as the cost of litigation mounts and its stock price gets pummeled once again," he added.

Monsanto was ordered on Wednesday to pay some $80 million to an American retiree who blames his cancer on the agribusiness giant’s weedkiller Roundup, in a case that could influence the outcome of thousands more like it.

A San Francisco jury found the firm, which is owned by Bayer, had been “negligent by not using reasonable care” to warn of the risks of its product, ordering it to pay Edwin Hardeman $75 million in punitive damages, a little over $5 million in compensation and $200,000 for medical expenses.

The jury also found that Roundup’s design was defective and that the product lacked sufficient warnings of potential risk.

The same jury had previously found that a quarter century exposure to Roundup, whose principal ingredient is controversial chemical glyphosate, was a “substantial factor” in giving the 70-year-old Hardeman non-Hodgkin’s lymphoma.

The verdict marks a major setback for Bayer, which purchased Monsanto last year for $63 billion and has seen its shares plunge because of the litigation.

A San Francisco jury found that Roundup's design was defective and that the product lacked suff...

A San Francisco jury found that Roundup's design was defective and that the product lacked sufficient warnings of potential risk
JOSH EDELSON, AFP/File

The company, which is facing thousands more similar lawsuits in the United States, said it would appeal the verdict even though it sympathized with Hardeman’s plight.

“We are disappointed with the jury’s decision, but this verdict does not change the weight of over four decades of extensive science and the conclusions of regulators worldwide that support the safety of our glyphosate-based herbicides and that they are not carcinogenic,” Bayer said in a statement.

“The verdict in this trial has no impact on future cases and trials, as each one has its own factual and legal circumstances.”

Hardeman’s attorneys, who cheered and hugged their client as the verdict was announced, described the decision by the six-member jury as historic and said it sends a clear message to Monsanto that it needs to change its business practices.

“It is clear from Monsanto’s actions that it does not care whether Roundup causes cancer, focusing instead on manipulating public opinion and undermining anyone who raises genuine and legitimate concerns about Roundup,” attorneys Aimee Wagstaff and Jennifer Moore said in a statement.

“It speaks volumes that not one Monsanto employee, past or present, came live to trial to defend Roundup’s safety or Monsanto’s actions.”

– ‘Back against the wall’ –

The case is one of more than 11,200 similar cases in the US alone involving Roundup.

Last year, Monsanto lost a case to a California school groundskeeper suffering from terminal non-Hodgkin’s lymphoma, who had sued the company over the glyphosate weedkillers Roundup and Ranger Pro.

Monsanto was initially ordered to pay $289 million to Dewayne Johnson, before the damages were reduced to $78.5 million

Bayer has also filed an appeal in that case.

Monsanto has consistently denied that the weedkiller causes cancer and challenged findings by the International Agency for Research on Cancer, an arm of the World Health Organization (WHO), which classified glyphosate as a “probable carcinogen” in 2015.

But other major agencies like the European Food Safety Authority (EFSA), the European Chemicals Agency (ECHA) or the US Environmental Protection Agency (EPA) have not followed suit.

The weedkiller glyphosate

The weedkiller glyphosate
Alain BOMMENEL, Laurence SAUBADU, Kun TIAN, AFP

Carl Tobias, a law professor at the University of Richmond, told AFP that Hardeman’s case was “important as a bellwether, which means it helps predict how future cases will be decided.”

Tobias said the verdict “bodes well” for plaintiffs in the thousands of other cases filed against Monsanto, and was “likely to encourage plaintiffs and their counsel to be more vigorous in pursuing their cases and will lead more potential plaintiffs to file suit.”

The Environmental Working Group, a non-profit, cheered Wednesday’s verdict.

“Clearly, the testimony that informed the jury’s decision was Bayer-Monsanto hiding Roundup’s carcinogenic properties, manipulating the science and cozying-up with EPA so it would not have to warn consumers of its dangerous product,” said the group’s president Ken Cook.

“This verdict puts Bayer’s back firmly up against the wall as the cost of litigation mounts and its stock price gets pummeled once again,” he added.

AFP
Written By

With 2,400 staff representing 100 different nationalities, AFP covers the world as a leading global news agency. AFP provides fast, comprehensive and verified coverage of the issues affecting our daily lives.

You may also like:

World

Calling for urgent action is the international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF)

World

Immigration is a symptom of a much deeper worldwide problem.

Business

Saudi Aramco President & CEO Amin Nasser speaks during the CERAWeek oil summit in Houston, Texas - Copyright AFP Mark FelixPointing to the still...

Business

A recent article in the Wall Street Journal infers that some workers might be falling out of the job market altogether.